MEI Pharma Inc

NASDAQ:MEIP   1:34:41 PM EDT
3.20
-0.06 (-1.84%)
Products

Mei Pharma And Kyowa Kirin Announce New Clinical Data On Zandelisib At American Society Of Clinical Oncology Annual Meeting 2021

Published: 05/19/2021 21:23 GMT
MEI Pharma Inc (MEIP) - Mei Pharma and Kyowa Kirin Announce New Clinical Data on Zandelisib at American Society of Clinical Oncology Annual Meeting 2021.
Mei Pharma Inc - Zandelisib and Zanubrutinib Combination Therapy Demonstrated 100% Response Rate in Patients With R/r Indolent B-cell Malignancies.
Mei Pharma - Research and Design of a Phase 3 Study Will Be Presented in Three Posters at American Society of Clinical Oncology Annual Meeting.